-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Madrigal Pharmaceuticals Says Resmetirom's Phase 3 Trial Shows Additional Positive Data Based on Pathologists' Analysis

Madrigal Pharmaceuticals Says Resmetirom's Phase 3 Trial Shows Additional Positive Data Based on Pathologists' Analysis

MT Newswires · 01/06/2023 06:50